Literature DB >> 34531946

Ir(III) Complex Dimer Nanoparticles for Photodynamic Therapy.

Yingjie Liu1,2, Dongxia Zhu3, Zhigang Xie1,2.   

Abstract

Iridium compounds are versatile in catalysis and photodynamic therapy. We present two Ir(III) complex dimers that can self-assemble into nanoparticles in the absence of adjuvant or surfactants. The formed nanoparticles possess a spherical morphology and robust colloidal stability and could be internalized by cancer cells. The Ir(III) complex nanoparticles have relatively strong photodynamic activity upon irradiation, which includes type I and type II reactive oxygen species. The generated reactive oxygen species could effectively induce cell death upon irradiation. This work highlights the potential of metal complexes and their nanoparticles in cancer treatment.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 34531946      PMCID: PMC8436240          DOI: 10.1021/acsmedchemlett.1c00362

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.632


  27 in total

1.  Evaluation of nano- and microparticle uptake by the gastrointestinal tract.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-12-01       Impact factor: 15.470

Review 2.  Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art.

Authors:  R H Müller; K Mäder; S Gohla
Journal:  Eur J Pharm Biopharm       Date:  2000-07       Impact factor: 5.571

3.  RuII complexes of "large-surface" ligands.

Authors:  Edith C Glazer; Yitzhak Tor
Journal:  Angew Chem Int Ed Engl       Date:  2002-11-04       Impact factor: 15.336

4.  Synthetic control of excited-state properties in cyclometalated Ir(III) complexes using ancillary ligands.

Authors:  Jian Li; Peter I Djurovich; Bert D Alleyne; Muhammed Yousufuddin; Nam N Ho; J Christopher Thomas; Jonas C Peters; Robert Bau; Mark E Thompson
Journal:  Inorg Chem       Date:  2005-03-21       Impact factor: 5.165

5.  Supramolecular self-assemblies as functional nanomaterials.

Authors:  Eric Busseron; Yves Ruff; Emilie Moulin; Nicolas Giuseppone
Journal:  Nanoscale       Date:  2013-08-21       Impact factor: 7.790

6.  Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery.

Authors:  Christin P Hollis; Heidi L Weiss; Markos Leggas; B Mark Evers; Richard A Gemeinhart; Tonglei Li
Journal:  J Control Release       Date:  2013-08-03       Impact factor: 9.776

7.  Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers.

Authors:  Yaxal Arenas; Susan Monro; Ge Shi; Arkady Mandel; Sherri McFarland; Lothar Lilge
Journal:  Photodiagnosis Photodyn Ther       Date:  2013-08-05       Impact factor: 3.631

Review 8.  Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.

Authors:  H Maeda; G Y Bharate; J Daruwalla
Journal:  Eur J Pharm Biopharm       Date:  2008-12-03       Impact factor: 5.571

Review 9.  Photodynamic therapy.

Authors:  T J Dougherty; S L Marcus
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

10.  AIE Multinuclear Ir(III) Complexes for Biocompatible Organic Nanoparticles with Highly Enhanced Photodynamic Performance.

Authors:  Liping Zhang; Yuanyuan Li; Weilong Che; Dongxia Zhu; Guangfu Li; Zhigang Xie; Nan Song; Shi Liu; Ben Zhong Tang; Xingman Liu; Zhongmin Su; Martin R Bryce
Journal:  Adv Sci (Weinh)       Date:  2019-01-21       Impact factor: 16.806

View more
  2 in total

1.  Dimensional Reduction Enhances Photodynamic Therapy of Metal-Organic Nanophotosensitizers.

Authors:  Taokun Luo; Yingjie Fan; Jianming Mao; Eric Yuan; Eric You; Ziwan Xu; Wenbin Lin
Journal:  J Am Chem Soc       Date:  2022-03-17       Impact factor: 16.383

Review 2.  Progress of Nanomaterials in Photodynamic Therapy Against Tumor.

Authors:  Lei Chen; Jiahui Huang; Xiaotong Li; Miaoting Huang; Shaoting Zeng; Jiayi Zheng; Shuyi Peng; Shiying Li
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.